Blood pressure drug boosts effectiveness of cancer therapy

Blood Pressure Drug Telmisartan Shows Promise in Boosting Cancer Therapy Effectiveness A groundbreaking study led by Dr. Tyler J. Curiel at the Dartmouth Cancer Center (DCC) reveals that telmisartan, an FDA-approved blood pressure medication, can significantly enhance the effectiveness of olaparib, a targeted cancer therapy. Published in The Journal for ImmunoTherapy of Cancer, the research … Read more

Systematic review identifies stress-induced biological triggers in oncology

Organ Mutation Rates Explain Cancer Risk Differences

The Silent Threat: How Chronic Stress is Rewriting the Rules of Cancer Care Stress is an unwelcome, yet constant, companion for anyone facing a cancer diagnosis. But emerging research reveals it’s far more than just an emotional burden. Chronic stress is increasingly recognized as a biological factor that can influence cancer progression, treatment response, and … Read more

New nanoparticle system boosts scalable production of therapeutic exosomes

The Future of Cell Therapy: Nanoparticles Supercharge Exosome Production The landscape of medicine is undergoing a significant shift, driven by advancements in cell therapy. Researchers at Xi’an Jiaotong-Liverpool University (XJTLU) have developed a groundbreaking method to streamline the production of engineered exosomes – tiny therapeutic particles released by cells – potentially unlocking faster access to … Read more

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study

GLP-1s: A Recent Chapter in Type 1 Diabetes Management? A groundbreaking analysis suggests glucagon-like peptide-1 receptor agonists (GLP-1RAs) – already well-established in type 2 diabetes treatment – could offer significant benefits for individuals living with type 1 diabetes (T1D). The research, published in Nature Medicine, points to reduced risks of cardiovascular events and kidney disease … Read more

Menopause may raise women’s Alzheimer risk earlier than doctors once thought

Alzheimer’s Prevention: Why Midlife is a Critical Window for Women A growing body of research suggests that the midlife transition, particularly menopause, represents a pivotal period for Alzheimer’s disease (AD) prevention in women. Traditionally, increased longevity was considered the primary reason women are disproportionately affected by AD – comprising nearly two-thirds of all cases. However, … Read more

App-based therapy helps men improve control over premature ejaculation

Tech-Enabled Intimacy: How Apps Are Redefining Men’s Sexual Health Premature ejaculation (PE) affects an estimated 30% of men, yet remains a largely unspoken and undertreated condition. A modern wave of digital health solutions, spearheaded by smartphone apps, is emerging to address this, offering a discreet and accessible alternative to traditional treatments. The Rise of Digital-First … Read more

Defining the limits of immunotherapy in early small-cell lung cancer

Immunotherapy Plateau? New Data Shifts Focus Back to Radiation in Small Cell Lung Cancer A recent international clinical trial, NRG-LU005, has delivered a nuanced message in the fight against limited-stage small cell lung cancer (LS-SCLC). While the addition of immunotherapy drug atezolizumab to standard chemoradiation didn’t significantly improve overall survival, a surprising trend emerged: twice-daily … Read more

Viagra ingredient improves symptoms in patients with Leigh syndrome

Viagra Ingredient Offers Hope for Rare Genetic Disorder, Leigh Syndrome A surprising discovery is offering a beacon of hope for families affected by Leigh syndrome, a devastating and previously untreatable genetic disorder. Sildenafil, the active ingredient in Viagra, has shown promising results in improving symptoms and potentially slowing the progression of this rare childhood disease. … Read more

FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer

Prostate Cancer Treatment Breakthrough: FOXJ1 Gene Holds Key to Overcoming Chemotherapy Resistance A newly discovered link between the FOXJ1 gene and resistance to taxane chemotherapy is offering fresh hope for patients battling advanced prostate cancer. Researchers at Weill Cornell Medicine and Beth Israel Deaconess Medical Center have identified FOXJ1 as a potential driver of drug … Read more

Mussel-inspired adhesive prevents organ rejection

Spray-On ‘Immune-Shield’ Offers Hope for Organ Transplant Success A groundbreaking new technology is offering a potential solution to one of the biggest hurdles in organ transplantation: immune rejection. Researchers at Pohang University of Science & Technology (POSTECH) and Ewha Womans University have developed an “Immune-Shield” – a sprayable adhesive coating containing immunosuppressants – designed to … Read more